Healthy Clinical Trial
Official title:
Interhemispheric Communication and Compensation in Peripheral Nerve Injury
The goal of this study is to determine which parts of the brain make it possible for some people to move skillfully with their left non-dominant hand.
Status | Recruiting |
Enrollment | 147 |
Est. completion date | December 2025 |
Est. primary completion date | December 1, 2025 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | This study contains two groups: typical controls and patients. Participants will be matched by age and sex between the two groups. No randomization will occur. A. Inclusion criteria (all participants): 1. Age = 18 2. English speaking and reading 3. Able to fit in Prisma scanner bore (60 cm diameter) 4. Right hand dominant (self report, and Edinburgh handedness = +40) B. Inclusion criteria (patients only): 1. Chronic unilateral upper extremity peripheral nerve injury to the right side - "Chronic" defined as = 6 months since injury - "Upper extremity" defined as hand, arm, or shoulder (including e.g. brachial plexus) - "Injury" defined as localized cause (e.g. mechanical/tumor, not distributed pathology), including compression 2. Some impairment to writing, requiring both of: - Difficulty writing, as determined by score 2+ (Mild+) on "How much difficulty have you had in the last week with writing?" (From Disabilities of the Arm, Shoulder, and Hand survey question #2) - Box and Blocks motor performance =1 standard deviation below the mean of age-matched healthy adults (Mathiowetz et al. 1985, AJOT). C. Exclusion criteria (all participants) 1. Currently intoxicated or otherwise non-compliant 2. Chronic pain diagnosis unrelated to the nerve injury 3. Uncorrected visual impairment that interferes with ability to see drawings in MRI 4. Motor function diagnoses that affect function of the left hand, now or in past 2 years 5. Motor function diagnoses currently affecting the right hand, unrelated to the nerve injury - This is not meant to exclude a single event with complex consequences (e.g. nerve and tendon) - This is not meant to exclude multiple nerve injuries in the same arm, if each one is eligible (II.B.1) - This is meant to exclude e.g. injury and unrelated musculoskeletal disorder in same arm 6. Upper extremity surgery, including peripheral nerve surgery, within last 2 months 7. Contraindication for MRI 8. Contraindication for transcranial magnetic stimulation (TMS) - May exclude from TMS only (since not all participants undergo TMS), or exclude from full study 9. Amputation affecting any part of thumb, index, or middle fingers (including higher level, e.g. whole hand) 10. History of chronic cocaine use (based on medical record or volunteered; will not actively inquire) 11. Diagnosis of schizophrenia or other rare psychiatric disorder - This is not meant to exclude depression or anxiety 12. History of major neurological diagnosis, e.g. stroke, traumatic brain injury, Alzheimer's, Parkinson's - This is not meant to exclude concussion UNLESS < 6 months ago, or post-concussion syndrome (diagnosed or self-report) D. Exclusion criteria (controls only) 1. Motor function diagnoses that affect function of either hand, now or in past 2 years |
Country | Name | City | State |
---|---|---|---|
United States | Washington University School of Medicine | Saint Louis | Missouri |
Lead Sponsor | Collaborator |
---|---|
Washington University School of Medicine | National Institute of Neurological Disorders and Stroke (NINDS) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | BOLD (blood oxygen level dependent) signal in ROIs (regions of interest) | BOLD signal in key ROIs (primary motor and posterior parietal cortex). ROI selection may be revisited after preliminary data review (35 participants) | Day 1 | |
Secondary | Drawing smoothness | Velocity smoothness in STEGA-MRI (Standardized Tracing Evaluation and Grapheme Assessment - MRI version) task | Day 1 | |
Secondary | Hand choice | Percentage of grasps made with right hand | Day 1 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |